Ventures L. P. BioAdvance, 10% Owner at NUPATHE INC. (PATH), sold 223,000 shares at $3.37 ($746K) on 2012-10-15, disclosed to the SEC on 2012-10-17.
Open-market sale of $746k PATH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.37 | 113,000 | $381K | 51.0% |
| 2 | $3.29 | 72,407 | $238K | 31.9% |
| 3 | $3.39 | 37,593 | $127K | 17.1% |
| Total | $3.35 avg | 223,000 | $746K | 100% |